Cardlytics Inc expected to post a loss of $1.35 a share - Earnings Preview

Cardlytics

04/08/2026 24:21

Cardlytics Inc CDLX.OQ CDLX.O is expected to  show a fall in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Atlanta Georgia-based  company is expected to report a 41.5% decrease in revenue to $37.003 million from $63.25 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on May 7 2026, for the period ended June 30, was for revenue between $35.00 million and $40.00 million.
​LSEG's mean analyst estimate for Cardlytics Inc is for a loss of $1.35 per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Cardlytics Inc is $10.00, about 145.7% above its last closing price of $4.07
The company's guidance on May 7 2026 for the period ended June 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 35 million and 1.3 million (USD).
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-1.90
-2.13
-1.10
Beat
48.4
Dec. 31 2026
-0.25
-0.70
0.30
Beat
142.9
Sep. 30 2025
-1.08
-1.50
-0.70
Beat
53.3​
Jun. 30 2025
-1.32
-1.62
-1.30
Beat
20
​​Mar. 31 2025
-1.99
-2.32
-2.10
Beat
9.7
Dec. 31 2024
-1.78
0.00
Beat
100​
Sep. 30 2024
-2.46
-2.42
-1.50
Beat
38
Jun. 30 2024
-1.10
-1.26
-1.50
Missed
-19
This summary was machine generated August 3 at 23:21 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)